Consider using Independent Monitoring or the Coverage Supervision Tool with MDA mop-up during the next round to improve coverage Tailor corrective action according to reasons given which include strengthening: Check the reasons for why the Drug supply chain eligible population was not Social mobilization and offered the drug information and education campaigns (look at reasons given by those who did swallow the drug) Check the reasons for the eligible Drug delivery platform used population not swallowing the Training, supervision and drug motivation of drug distributors Communication on adverse events Capacity of national and/or district level staff Communities and drug Survey coverage is Congratulate your teams. Sustain distributors are motivated and above the target programme momentum for the next the programme is functioning coverage thresholdb year to maintain coverage levels well Comparison of survey coverage with reported coverage: To check if the data reporting system is working well Conduct a Data Quality or Data Quality Assessmentf to diagnose where the data reporting system is breaking down Drug distributors are incorrectly reporting on ingestion of the Improve the skills and motivation of Reported coverage is drugs drug distributors through better much higher than training and supervision; consider use survey coveragec of mHealth technologies (i.e., routine reporting is Make improvements to the tally likely overestimating sheets and/or registers used true coverage) The total population figure (e.g., Determine if more accurate the denominator) is incorrect or population estimates or projections outdated, or people from outside are available and apply a correction the survey area are also taking factor to routine coverage estimates the drugs and are being included as appropriate in the total treatment tallies
Consider using Independent Monitoring or the Coverage Supervision Tool with MDA mop-up during the next round to improve coverage Check the reasons for why the eligible population was not offered the drug Check the reasons for the eligible population not swallowing the drug Tailor corrective action according to reasons given which include strengthening: Drug supply chain Social mobilization and information and education campaigns (look at reasons given by those who did swallow the drug) Drug delivery platform used Training, supervision and motivation of drug distributors Communication on adverse events Capacity of national and/or district level staff Survey coverage is above the target coverage thresholdb Communities and drug distributors are motivated and the programme is functioning well Congratulate your teams. Sustain programme momentum for the next year to maintain coverage levels Comparison of survey coverage with reported coverage: To check if the data reporting system is working well Reported coverage is much higher than survey coveragec (i.e., routine reporting is likely overestimating true coverage) Drug distributors are incorrectly reporting on ingestion of the drugs Conduct a Data Quality or Data Quality Assessmentf to diagnose where the data reporting system is breaking down Improve the skills and motivation of drug distributors through better training and supervision; consider use of mHealth technologies Make improvements to the tally sheets and/or registers used The total population figure (e.g., the denominator) is incorrect or outdated, or people from outside the survey area are also taking the drugs and are being included in the total treatment tallies Determine if more accurate population estimates or projections are available and apply a correction factor to routine coverage estimates as appropriate
who_coverage_evaluation_survey_guidance.docx